597 related articles for article (PubMed ID: 12516902)
1. Surveillance of neural tube defects in Israel.
Zlotogora J; Amitai Y; Kaluski DN; Leventhal A
Isr Med Assoc J; 2002 Dec; 4(12):1111-4. PubMed ID: 12516902
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of neural tube defects in Israel: the effect of the recommendation for periconceptional folic acid.
Zlotogora J; Amitai Y; Leventhal A
Isr Med Assoc J; 2006 Sep; 8(9):601-4. PubMed ID: 17058407
[TBL] [Abstract][Full Text] [Related]
3. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China.
Li Z; Ren A; Zhang L; Ye R; Li S; Zheng J; Hong S; Wang T; Li Z
Birth Defects Res A Clin Mol Teratol; 2006 Apr; 76(4):237-40. PubMed ID: 16575897
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiology of prenatal diagnosis and selective pregnancy termination because of fetal neural tube defects in The Netherlands in comparison to other European countries].
Cornel MC; Leurquin P; de Walle HE; Staal-Schreinemachers AL; Beekhuis JR
Ned Tijdschr Geneeskd; 1997 Nov; 141(46):2239-44. PubMed ID: 9550786
[TBL] [Abstract][Full Text] [Related]
5. Decline of neural tube defects cases after a folic acid campaign in Nuevo León, México.
Martínez de Villarreal L; Pérez JZ; Vázquez PA; Herrera RH; Campos Mdel R; López RA; Ramírez JL; Sánchez JM; Villarreal JJ; Garza MT; Limón A; López AG; Bárcenas M; García JR; Domínguez AS; Nuñez RH; Ayala JL; Martínez JG; González MT; Alvarez CG; Castro RN
Teratology; 2002 Nov; 66(5):249-56. PubMed ID: 12397633
[TBL] [Abstract][Full Text] [Related]
6. [Sex distribution of neural tube defects and their birth outcome in high- and low-prevalence areas of China].
Pei LJ; Li Z; Li S; Hong SX; Wang H; Wang TM; Zhao XQ; Guan YB; Xiao L; Wang LN
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Sep; 37(5):338-41. PubMed ID: 14680596
[TBL] [Abstract][Full Text] [Related]
7. Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991.
Roberts HE; Moore CA; Cragan JD; Fernhoff PM; Khoury MJ
Pediatrics; 1995 Nov; 96(5 Pt 1):880-3. PubMed ID: 7478829
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of neural tube defects in 16 regions of Europe, 1980-1983. The EUROCAT Working Group.
Int J Epidemiol; 1987 Jun; 16(2):246-51. PubMed ID: 3610451
[TBL] [Abstract][Full Text] [Related]
9. Lower rates of neural tube defects in Israel following folic acid supplementation policy.
Reiss A; Cohen MJ; Kaliner E; Gabai Kapara E; Singer A; Grotto I; Gamzu R
Prev Med; 2020 Oct; 139():106064. PubMed ID: 32220587
[TBL] [Abstract][Full Text] [Related]
10. Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification.
Bower C; D'Antoine H; Stanley FJ
Birth Defects Res A Clin Mol Teratol; 2009 Apr; 85(4):269-73. PubMed ID: 19180646
[TBL] [Abstract][Full Text] [Related]
11. Etiology, pathogenesis and prevention of neural tube defects.
Padmanabhan R
Congenit Anom (Kyoto); 2006 Jun; 46(2):55-67. PubMed ID: 16732763
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of a neural tube defect recurrence-prevention program.
Grosse SD; Ouyang L; Collins JS; Green D; Dean JH; Stevenson RE
Am J Prev Med; 2008 Dec; 35(6):572-7. PubMed ID: 18845415
[TBL] [Abstract][Full Text] [Related]
13. [Etiologic and epidemiologic aspects of neural tube defects].
Stoll C; Dott B; Roth MP; Alembik Y
Arch Fr Pediatr; 1988 Nov; 45(9):617-22. PubMed ID: 3069067
[TBL] [Abstract][Full Text] [Related]
14. Are encephaloceles neural tube defects?
Rowland CA; Correa A; Cragan JD; Alverson CJ
Pediatrics; 2006 Sep; 118(3):916-23. PubMed ID: 16950981
[TBL] [Abstract][Full Text] [Related]
15. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid.
Heseker HB; Mason JB; Selhub J; Rosenberg IH; Jacques PF
Br J Nutr; 2009 Jul; 102(2):173-80. PubMed ID: 19079944
[TBL] [Abstract][Full Text] [Related]
16. The apparently declining prevalence of neural tube defect in two counties in South Wales over three decades illustrating the need for continuing action and vigilance.
Laurence KM
Z Kinderchir; 1985 Dec; 40 Suppl 1():58-60. PubMed ID: 2418600
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of passive surveillance for NTD-affected births in Alaska: a case verification study, birth years 1996-2007.
Schoellhorn KJ; Collins S
J Registry Manag; 2010; 37(1):4-9. PubMed ID: 20795563
[TBL] [Abstract][Full Text] [Related]
18. Decreasing prevalence of neural tube defects in Utah, 1985-2000.
Feldkamp M; Friedrichs M; Carey JC
Teratology; 2002; 66 Suppl 1():S23-8. PubMed ID: 12239740
[TBL] [Abstract][Full Text] [Related]
19. Genetic heterogeneity in neural tube defects.
Simpson JL; Mills J; Rhoads GG; Cunningham GC; Conley MR; Hoffman HJ
Ann Genet; 1991; 34(3-4):279-86. PubMed ID: 1809238
[TBL] [Abstract][Full Text] [Related]
20. [Folic acid use by pregnant women in Israel for preventing neural tube defects].
Gil Z; Aran A; Friedman O; Beni-Adani L; Constantini S
Harefuah; 2000 Dec; 139(11-12):416-20, 495. PubMed ID: 11341184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
